Intellectual Property India Publishes Patent Application for 'Membrane-Associated Protein Biomarker Panel And Kit For Differentiating Cisplatin Resistant From Cisplatin-Sensitive Triple-Negative Breast Cancer (TNBC)' Filed by Indian Institute Of Technology

MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202521126139 A) filed by Indian Institute Of Technology, Maharashtra, on Dec. 12, 2025, for 'membrane-associated protein biomarker panel and kit for differentiating cisplatin resistant from cisplatin-sensitive triple-negative breast cancer (tnbc).'

Inventor(s) include Shashwati Parihari; Saheli Sarkar; and Sanjeeva Srivastava.

The application for the patent was published on May 1, under issue no. 18/2026.

According to the abstract released by the Intellectual Property India: "Membrane-Associated Protein Biomarker Panel and Kit for Differentiating Cisplatin-Resistant from Cisplatin-Sensitive Triple-Negative Breast Cancer (TNBC). Membrane-associated pro...